SMU alum moves company headquarters to Houston, announce residency at the world’s largest medical complex

“The TMC ecosystem provides us with numerous opportunities for collaborations and partnerships that will undoubtedly play key roles in the commercialization of our technology,” said Edward Allegra, co-founder and CEO of BioLum Sciences. “We couldn’t be more excited to be surrounded by other startups and industry leaders who are at the forefront of healthcare innovation.”BioLum is recognized as one of the Top 4 Asthma Tech Startups in the U.S. by MedTech Boston. It recently completed major development milestones including a partnership with a large hospital network to further clinical studies and trials. As a resident company at JLABS, BioLum will continue to focus on the growth of key strategic industry partnerships and prepare for the FDA regulatory process. View MedTech Boston article here: https://bit.ly/2NkD5MS

BioLum is now a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers.

JLABS is a 34,000 square-foot life science innovation center. The labs provide a flexible environment for start-up companies pursuing new technologies to advance medical care. Through a “no strings attached” model, JJI does not take an equity stake in the companies occupying JLABS and the companies are free to develop products – either on their own, or by initiating a separate external partnership with JJI or any other company.

About BioLum Sciences

BioLum Sciences, LLC is the developer of a medical device, the BioSense AMD (Airway Monitoring Device), that aids in the diagnosis and monitoring of respiratory diseases, such as asthma and COPD, by enabling patients to measure airway inflammation with a quick and reliable test.

BioLum’s team comprises an effective partnership between entrepreneurial expertise and scientific innovation. BioLum has capitalized on the thriving business sector in the Dallas area to develop partnerships and a strong consultant network; now they look to expand this network into Houston.

BioLum Sciences and other JLABS residents can be found on the Johnson and Johnson Innovation website here: https://jlabs.jnjinnovation.com/companies/biolum-sciences